Search results
Results from the WOW.Com Content Network
In 2015, GAFFI proposed action to make fungal diagnostic tests and antifungal treatments available to 95% of the world's population by 2025 95/95 by 2025 Archived 2023-04-11 at the Wayback Machine. Six actions were proposed: Provide rapid diagnostic tests that do not rely on culture, and that are affordable. [1] [2]
Amphotericin B is an antifungal medication used for serious fungal infections and leishmaniasis. [3] The fungal infections it is used to treat include mucormycosis , aspergillosis , blastomycosis , candidiasis , coccidioidomycosis , and cryptococcosis . [ 4 ]
Posaconazole, sold under the brand name Noxafil among others, is a triazole antifungal medication. [7] [8] It was approved for medical use in the European Union in October 2005, [6] and in the United States in September 2006. [5] [9] It is available as a generic medication. [10] [11]
Ketoconazole, sold under the brand name Nizoral, among others, is an antiandrogen, antifungal, and antiglucocorticoid medication used to treat a number of fungal infections. [11] Applied to the skin it is used for fungal skin infections such as tinea , cutaneous candidiasis , pityriasis versicolor , dandruff , and seborrheic dermatitis . [ 12 ]
Isavuconazonium, sold under the brand name Cresemba, is a systemic antifungal medication of the triazole class which is used to treat invasive aspergillosis and mucormycosis. [9] [7] [8] [12] It is used as the sulfate. [9] It is taken by mouth or given via injection into a vein. [9]
A national coverage determination (NCD) [1] is a United States nationwide determination of whether Medicare will pay for an item or service. [2] It is a form of utilization management and forms a medical guideline on treatment.
Medicare Part B, on the other hand, charges beneficiaries a standard monthly premium of $174.70. While Part B premiums cover about 25 percent of program costs, general revenue subsidies cover the ...
Antifungal resistance is a One Health concern, driven by multiple extrinsic factors, including extensive fungicidal use, overuse of clinical antifungals, environmental change and host factors. [ 1 ] Like resistance to antibacterials, antifungal resistance can be driven by antifungal use in agriculture.